COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS
    9.
    发明申请
    COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS 失效
    化合物和组合物作为通道激活蛋白酶抑制剂

    公开(公告)号:US20100056756A1

    公开(公告)日:2010-03-04

    申请号:US12526029

    申请日:2008-01-07

    IPC分类号: C07K5/08

    摘要: The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating channel activating proteases, and methods for, using such compounds to treat, ameliorate or prevent a condition associated with a channel activating protease, including but not limited to prostasin, PRSS22, TMPRSS11 (e.g., TMPRSS11B, TMPRSS11E), TMPRSS2, TMPRSS3, TMPRSS4 (MTSP-2), matriptase (MTSP-1), CAP2, CAP3, trypsin, cathepsin A, or neutrophil elastase.

    摘要翻译: 本发明提供了可用于调节通道活化蛋白酶的化合物及其药物组合物,以及使用这些化合物治疗,改善或预防与通道活化蛋白酶(包括但不限于前列腺素PRSS22,TMPRSS11)相关的病症的方法 (例如TMPRSS11B,TMPRSS11E),TMPRSS2,TMPRSS3,TMPRSS4(MTSP-2),matriptase(MTSP-1),CAP2,CAP3,胰蛋白酶,组织蛋白酶A或嗜中性粒细胞弹性蛋白酶。